SCHEMBL27632004

SCHEMBL27632004

[CH2]C(C)(C)Oc1cccc([N+](=O)[O-])c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.52
LMNA P02545 1/20 0.52
CHRNB2 P17787 1/20 0.50
CHRNA4 P43681 1/20 0.50
ACHE P22303 1/20 0.49
ALDH1A1 P00352 4/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
F2 P00734 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALOX15 P16050 1/20 0.44
PTPRC P08575 1/20 0.44
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
HSP90AA1 P07900 1/20 0.43
NFE2L2 Q16236 1/20 0.43
CHRNB4 P30926 1/20 0.43
CHRNA3 P32297 1/20 0.43
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL677718 0.86 TSHR (0.55) TSHRLMNACHRNB2CHRNA4ACHE
SCHEMBL7146151 0.85 CHRNB2 (0.55) TSHRLMNACHRNB2CHRNA4ACHE
SCHEMBL27842046 0.83 TSHR (0.52) TSHRLMNACHRNB2CHRNA4ACHE
SCHEMBL15228420 0.83 TSHR (0.52) TSHRLMNACHRNB2CHRNA4ACHE
SCHEMBL9162898 0.81 TSHR (0.48) TSHRLMNACHRNB2CHRNA4ACHE
SCHEMBL19387684 0.81 CHRNB2 (0.51) TSHRLMNACHRNB2CHRNA4ACHE
SCHEMBL14931865 0.80 PPARA (0.49) TSHRLMNACHRNB2CHRNA4ACHE
SCHEMBL7111679 0.80 MEN1 (0.48) TSHRLMNACHRNB2CHRNA4ACHE
SCHEMBL1130974 0.79 KMT2A (0.58) TSHRLMNACHRNB2CHRNA4ACHE
SCHEMBL10513091 0.79 TSHR (0.55) TSHRLMNACHRNB2CHRNA4ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1678321-A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds RIGEL PHARMACEUTICALS INC (US) 2005-10-05 CN disclosed